Effect of finerenone on renal function in patients with type 2 diabetic nephropathy: a retrospective cohort study

BackgroundDiabetic nephropathy (DN) remains a major cause of chronic kidney disease despite optimized renin–angiotensin system blockade. This study aimed to evaluate the efficacy and safety of adding finerenone to angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (ACEI/ARB) the...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xu-Ying Liu, Ya-Min Zhao, Ya-Guang Zhang, Yi Liu, Bo-Ya Wang, Zhen-Zhen Hao, Man-Hui Hu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-02-01
Edice:	Frontiers in Endocrinology
Témata:	albuminuria chronic kidney disease diabetic nephropathies finerenone glomerular filtration rate
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fendo.2026.1753126/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!